Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy

Gastroenterology

Volumn 102, Issue 4 PART 1, 1992, Pages 1389-1391

  Perdigoto, Rui ^a   Wiesner, Russell H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; DISEASE COURSE; DRUG EFFICACY; DUODENOSCOPY; ESOPHAGOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FATIGUE; FEMALE; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS;

AGED; CASE REPORT; FEMALE; HUMAN; LIVER CIRRHOSIS, BILIARY; MIDDLE AGE; URSODEOXYCHOLIC ACID;

EID: 0026518805     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(92)70038-d     Document Type: Article

References (15)

1. Primary biliary cirrhosis
2. Clinical and statistical analysis of new and evolving therapies for primary biliary cirrhosis
3. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
4. Ursodeoxycholic acid and primary biliary cirrhosis: results of a controlled double-blind trial
5. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis
6. Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis
7. Effect of different doses of ursodeoxycholic acid in chronic liver disease
8. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis: interim analysis of a double-blind multicenter randomized trial
9. Beneficial effect of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Final results of the French Canadian trial (abstr)
10. A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis
11. Effects of ursodeoxycholic acid (UDca) on hepatic function and portal hypertension in primary biliary cirrhosis (PBC) (abstr)
12. No symptomatic or histological benefit from ursodeoxycholic acid treatment in PBC after 1 year controlled pilot study (abstr)
13. A randomized controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) (abstr)
14. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid (letter)
15. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)